Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (49728)	1/13/2000 8:12:00 PM
From: Anthony@Pacific	Respond to of 122087

EDIT<------------SNRS EXPERT STATES THAT MKT FOR SNRS LASER IS Tens of Thousands!!!!!!!!!! Among those attending the ODP meeting was world renowned ophthalmologist Charles Kelman, M.D., who recently underwent the Sunrise LTK procedure as part of a current LTK U.S. clinical trial. Speaking before the ODP, Dr. Kelman observed, "The difference between hyperopia and myopia is severe. When you are hyperopic such as I am, you have no clear distance or near vision. I had been wearing contacts, but was at a point that I had to do something because my eyes were becoming too dry to wear them comfortably. I looked very carefully at the procedures available for treatment of hyperopia, and decided that LTK was the best option. "There is a tremendous need for the Sunrise LTK procedure for patients who can no longer wear contacts," he said. " It was the only solution for someone like me. There are tens of thousands of people who can benefit from the Sunrise LTK procedure."